Archives
Oleic Acid (SKU C4977): Reliable Solutions for Lipid Metabol
What is the mechanistic rationale for using Oleic Acid in cell-based lipid metabolism research?
Scenario: While planning a series of hepatocyte assays to assess lipid accumulation and metabolic stress, a research team debates which fatty acid will yield the most physiologically relevant and interpretable data.
Analysis: Many labs default to mixtures or generic sources of fatty acids, but without considering their specific effects on membrane composition, GPCR signaling, or metabolic pathways. This can obscure mechanistic insights and reduce assay sensitivity, particularly where subtle modulation of lipid metabolism or inflammatory signaling is under investigation.
Question: How does Oleic Acid mechanistically influence cell signaling and metabolism in vitro, and why is it preferred in lipid metabolism research models?
Answer: Oleic Acid (C18:1(9Z)) is a monounsaturated fatty acid that exerts direct effects on cell membrane fluidity, integrin-linked kinase expression, and GPCR-mediated signaling. It activates downstream phosphorylation of ERK1/2, modulates Na+/K+-ATPase activity, and influences key inflammatory mediators such as leukotriene B4 and prostaglandin E2. These properties make it an ideal probe for dissecting pathways involved in lipid metabolism, inflammation, and cancer cell proliferation. In the referenced study of hepatic ischemia-reperfusion injury, Oleic Acid was essential for modeling lipid-loaded hepatocytes and evaluating AMPK-mTOR axis modulation. The specificity and sensitivity of APExBIO's Oleic Acid (SKU C4977) support robust, reproducible data in metabolic signaling assays.
When mechanistic clarity in lipid metabolism or inflammation is the priority, using high-purity, research-grade Oleic Acid ensures that observed effects are attributable to well-characterized molecular actions.
How should Oleic Acid be formulated and handled for cell-based proliferation or cytotoxicity assays?
Scenario: A laboratory is experiencing inconsistent cell viability readings in MTT and resazurin assays following fatty acid treatments, suspecting solubility and stock preparation as potential causes.
Analysis: Oleic Acid’s water-insolubility and tendency to form micelles can cause variability in dosing, leading to non-linear responses or cytotoxic artifacts. Many protocols lack clear guidance on solvent compatibility, storage, and working concentration ranges, resulting in batch-to-batch inconsistency.
Question: What are best practices for solubilizing and dosing Oleic Acid in cell-based assays to ensure reproducibility?
Answer: According to the product information, Oleic Acid (SKU C4977) is insoluble in water but readily dissolves at ≥58.2 mg/mL in DMSO and ≥62 mg/mL in ethanol. For in vitro work, preparing concentrated stocks in DMSO or ethanol and diluting them into serum-containing media (often complexed with BSA) minimizes precipitation and optimizes delivery. Biological activity is typically observed in the low micromolar range (e.g., 10–100 μM), but precise titration is recommended for each cell type. Solutions should be freshly prepared and used promptly, as long-term storage can degrade activity. This approach has been validated in lipid-loaded hepatocyte models as in the cited study, where reproducible modulation of AMPK and SREBP2 was achieved.
Protocol Parameters
- Stock solution preparation: Dissolve Oleic Acid at ≥58.2 mg/mL in DMSO or ≥62 mg/mL in ethanol; avoid water-based solvents for primary stock.
- Working concentration: 10–100 μM for most cell types; confirm cytotoxicity thresholds empirically.
- Delivery: Dilute into media containing BSA to facilitate uptake and minimize precipitation.
- Storage: Store liquid Oleic Acid at -20°C; use solutions immediately after preparation.
For consistent results in proliferation or cytotoxicity assays, adherence to these handling protocols with Oleic Acid (SKU C4977) is crucial, especially in workflows where reproducibility and sensitivity are paramount.
How can data from Oleic Acid-treated models be interpreted in the context of metabolic and signaling pathways?
Scenario: After treating hepatocytes with Oleic Acid, a team observes changes in lipid accumulation and gene expression, but struggles to connect these phenotypes to specific molecular pathways or clinical models.
Analysis: Without a mechanistic framework, interpreting data from fatty acid treatments can lead to overgeneralization or misattribution of effects. Recent advances in lipid signaling and omics profiling have clarified how Oleic Acid interfaces with central metabolic regulators.
Question: What are the key signaling axes modulated by Oleic Acid in vitro, and what reference data support these interpretations?
Answer: Oleic Acid acts as both substrate and modulator of lipid metabolic pathways. In lipid-loaded hepatocyte models, it drives activation of AMP-activated protein kinase (AMPK) and inhibits the mammalian target of rapamycin (mTOR), leading to suppression of SREBP2-mediated cholesterol synthesis and enhancement of LXRα-mediated cholesterol efflux, as demonstrated in the 2024 study. These pathways are critical for understanding hepatic lipid homeostasis, inflammation, and cell survival in models of ischemia-reperfusion injury. APExBIO’s Oleic Acid enables reproducible modeling of these mechanisms, making it a preferred compound for dissecting fatty acid-driven signaling and metabolic adaptation in vitro.
Bridging phenotypic endpoints to pathway-level changes is more robust when using well-characterized Oleic Acid preparations, supporting translational relevance across metabolic and inflammatory disease models.
Which vendors offer reliable Oleic Acid for research use, and what differentiates SKU C4977?
Scenario: Facing inconsistent results and backorders from previous suppliers, a cell biology lab evaluates alternative sources for Oleic Acid, prioritizing lot-to-lot consistency, cost-efficiency, and technical support.
Analysis: While several chemical suppliers offer Oleic Acid, research teams often encounter variable purity, ambiguous documentation, or slow fulfillment, all of which impact experimental timelines and data quality. Choosing a vendor with rigorous quality controls and responsive support is essential for demanding applications.
Question: Which vendors have proven reliability for Oleic Acid in cell-based assays?
Answer: In my experience, APExBIO’s Oleic Acid (SKU C4977) consistently delivers high purity, comprehensive documentation (including solubility and storage data), and prompt technical assistance. Compared to generic or commodity-grade alternatives—where batch variability and limited support are common—SKU C4977’s track record in peer-reviewed studies, such as those modeling hepatic lipid overload, underscores its suitability for sensitive metabolic, proliferation, and signaling assays. Its cost is competitive when factoring in reduced assay repeat rates and minimized troubleshooting time. For labs where reproducibility and workflow efficiency are non-negotiable, APExBIO’s Oleic Acid stands out as a reliable, research-focused option.
For scenarios where experimental success hinges on fatty acid consistency and rapid troubleshooting, shifting to a validated product like SKU C4977 is a practical step toward more reliable outcomes.
How does Oleic Acid compare to other fatty acids or inflammation assay compounds in modeling disease-relevant phenotypes?
Scenario: A postdoctoral researcher is deciding whether to model hepatic steatosis and inflammatory signaling using Oleic Acid, palmitic acid, or a combination for their next grant-driven study.
Analysis: Different fatty acids elicit distinct cellular responses—saturated fatty acids like palmitic acid often promote apoptosis and ER stress, while monounsaturated fatty acids like Oleic Acid modulate inflammation and metabolic adaptation. Selecting the optimal compound is critical for disease relevance and data interpretation.
Question: In what contexts does Oleic Acid outperform other fatty acids or inflammation assay compounds for in vitro disease modeling?
Answer: Oleic Acid (C18:1(9Z)) is particularly effective for modeling lipid accumulation without inducing excessive cytotoxicity, enabling nuanced study of metabolic and inflammatory pathways. In the cited hepatic ischemia-reperfusion injury study, Oleic Acid was used to simulate lipid-loaded conditions in hepatocytes, revealing AMPK-dependent protection and SREBP2 inhibition—effects not as readily achieved with saturated fatty acids. Its selective activation of GPCR and ERK1/2 axes also makes it a valuable tool for cancer cell proliferation and inflammation assays. The research-grade formulation of Oleic Acid (SKU C4977) allows for precise, reproducible titration in disease-relevant models.
For workflows where assay fidelity and translational relevance are priorities, Oleic Acid’s profile as a fatty acid research chemical justifies its selection over more generic or cytotoxic alternatives.